MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q3
hinzugefügt 03.11.2022
SeaSpine Holdings Corporation Langfristige Verbindlichkeiten 2011-2026 | SPNE
Langfristige Verbindlichkeiten Jährlich SeaSpine Holdings Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 12 M | 1.48 M | 3.71 M | 5.66 M | 11.8 M | 3.02 M | 2.41 M | 3.56 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 12 M | 1.48 M | 5.44 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
Align Technology
ALGN
|
184 M | $ 165.05 | -6.92 % | $ 12.4 B | USA |
 |
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Alphatec Holdings
ATEC
|
89.9 M | $ 10.98 | -4.69 % | $ 1.65 B | USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
Abbott Laboratories
ABT
|
25.7 B | $ 105.06 | 0.47 % | $ 183 B | USA |
 |
Accuray Incorporated
ARAY
|
196 M | $ 0.39 | 3.73 % | $ 40.1 M | USA |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 34.24 | -3.13 % | $ 5.1 K | USA |
 |
Boston Scientific Corporation
BSX
|
11.8 B | $ 69.19 | -1.4 % | $ 102 B | USA |
 |
ClearPoint Neuro
CLPT
|
23.9 M | $ 9.18 | -2.25 % | $ 260 M | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
8.87 K | $ 24.63 | 0.74 % | $ 208 M | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 35.38 | -3.44 % | $ 1.1 B | USA |
 |
Establishment Labs Holdings
ESTA
|
53.7 M | $ 55.71 | -7.01 % | $ 1.65 B |  Costa-rica |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
FONAR Corporation
FONR
|
36.4 M | $ 18.55 | 0.03 % | $ 122 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
18 | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M |  Canada |
 |
Helius Medical Technologies
HSDT
|
252 K | $ 1.92 | -4.48 % | $ 1.17 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.56 B | $ 9.32 | -0.64 % | $ 718 M | USA |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
Inogen
INGN
|
52.5 M | $ 6.27 | -3.54 % | $ 167 M | USA |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.59 | -1.5 % | $ 32.1 M | USA |
 |
Aethlon Medical
AEMD
|
42.5 K | $ 2.24 | -1.32 % | $ 3.5 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.44 B | $ 78.78 | -4.04 % | $ 46.1 B | USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
424 M | $ 11.25 | -1.4 % | $ 1.52 B | USA |
 |
Penumbra
PEN
|
89.2 M | $ 335.11 | -0.39 % | $ 13 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
116 M | $ 15.72 | -3.85 % | $ 369 M | USA |
 |
LivaNova PLC
LIVN
|
516 M | $ 61.25 | -3.77 % | $ 3.34 B |  Britain |
 |
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
4.53 M | - | 10.0 % | $ 610 K | USA |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 0.99 | -26.48 % | $ 16 M | USA |
 |
IRadimed Corporation
IRMD
|
4.76 M | $ 97.44 | -1.32 % | $ 1.24 B | USA |
 |
Myomo
MYO
|
275 K | $ 0.67 | -1.56 % | $ 28 M | USA |